Mecga Biotechnology

We are building toward a future in which the quality of a physiological measurement is set by the model interpreting it rather than by the instrumentation and conditions required to capture it -- making continuous, high-fidelity monitoring viable well beyond the settings that support it today. Mecga Biotechnology Corporation was founded by Jay Beom Kim (Biology, Florida State University), Jooney Han (Computing, Imperial College London), and Daniel Sanghyun You (Mathematics, University of Chicago) -- a team that brings together the physiology, the systems engineering, and the mathematics the problem requires. Biomedical signals are measured through a hostile interface. Skin moves, muscles fire, electrodes shift, and the clinically meaningful features of a waveform are small relative to everything else a sensor picks up. As cardiac monitoring has moved out of the clinic and into fourteen-day patches and wearable devices, the volume of recording has grown enormously -- and so has the share of it taken under exactly the conditions that corrupt it. The prevailing responses are all forms of subtraction: discard the unreadable segments, escalate them to human review, or filter hard enough to remove the artifact and accept the morphological distortion that comes with it. Mecga Bio builds the alternative. Our restoration layer recovers usable signal from corrupted recordings, preserving the waveform structure that downstream systems and clinicians depend on. We do not interpret or diagnose; we restore fidelity, and the systems already cleared to read these signals do the rest. Mecga is a research company first: the method development, the validation across device geometries and signal modalities, and the peer-reviewed work behind them are the engine of the product, not an adjunct to it.